Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
KRAS and TP53 co-mutation predicts benefit of immune chec... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma
0
Authors
Jan Budczies
15 more
Jan Budczies
•
Martina Kirchner
13 more
•
Albrecht Stenzinger
Published
June 12, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
British Journal of Cancer
Topics
Biology
Cancer Oncology
Medicine
Internal Medicine
Cancer Research
Show all topics
DOI
10.1038/s41416-024-02746-z
License
CC-BY
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
British Journal of Cancer
Topics
Biology
Cancer Oncology
Medicine
Internal Medicine
Cancer Research
Show all topics
DOI
10.1038/s41416-024-02746-z
License
CC-BY
Other Formats
PDF
